Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

about

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

Item

http://www.wikidata.org/entity/Q42208054

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

@en

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

@nl

type

Item

label

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

@en

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

@nl

prefLabel

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

@en

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

@nl

P1476

Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic.

@en

P2093

Kuen S Lee

http://www.w3.org/2001/XMLSchema#string

Luis A Quiñones

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics: playing the odds

Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy.

Prediction of individual response to anticancer therapy: historical and future perspectives

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine, administered with tetrahydrouridine

Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer.

Moving towards individualized medicine with pharmacogenomics.

Cytochrome P450 gene polymorphism and cancer.

Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.

Pharmacogenomics in oncology care

Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer.

P304

195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3389/FGENE.2015.00195

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278788407

http://www.w3.org/2001/XMLSchema#string

P698

26089835

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

4452881

http://www.w3.org/2001/XMLSchema#string